Spebrutinib 5 mg | 97.14%
TargetMol
Spebrutinib is an orally bioavailable, selective inhibitor of Bruton’s agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity.
More Information Supplier PageSpebrutinib
Search Results
PIK-93 25 mg | 99.83%
TargetMol
PIK-93 is the first potent, synthetic PI4K inhibitor with IC50 of 19 nM; inhibits PI3Kα with IC50 of 39 nM.
More Information Supplier PagePIK-93
PIK-93 10 mg | 99.83%
TargetMol
PIK-93 is the first potent, synthetic PI4K inhibitor with IC50 of 19 nM; inhibits PI3Kα with IC50 of 39 nM.
More Information Supplier PagePIK-93
CEP-28122 5 mg | Purity Not Available
TargetMol
CEP-28122 is a highly potent and selective orally active ALK inhibitor.
More Information Supplier PageCEP-28122
CEP-28122 2 mg | Purity Not Available
TargetMol
CEP-28122 is a highly potent and selective orally active ALK inhibitor.
More Information Supplier PageCEP-28122
CEP-28122 25 mg | Purity Not Available
TargetMol
CEP-28122 is a highly potent and selective orally active ALK inhibitor.
More Information Supplier PageCEP-28122
CEP-28122 1 mg | Purity Not Available
TargetMol
CEP-28122 is a highly potent and selective orally active ALK inhibitor.
More Information Supplier PageCEP-28122
CEP-28122 10 mg | Purity Not Available
TargetMol
CEP-28122 is a highly potent and selective orally active ALK inhibitor.
More Information Supplier PageCEP-28122
Prucalopride 50 mg | 100.00%
TargetMol
Prucalopride is a selective, high-affinity 5-HT4A/4B receptor agonist (Ki: 2.5/8 nM). It has >290-fold selectivity for 5-HT4A/4B receptor than other 5-HT receptor subtypes.
More Information Supplier PagePrucalopride
Pimozide 50 mg | 99.63%
TargetMol
Pimozide is a diphenylbutylpiperidine derivative and a dopamine antagonist with the antipsychotic property. Pimozide selectively inhibits type 2 dopaminergic receptors in the central nervous system (CNS), thereby decreasing dopamine neurotransmission and reducing the occurrence of the motor and vocal tics and delusions of parasitosis. In addition, this agent antagonizes alpha-adrenergic and 5-HT2 receptors.
More Information Supplier PagePimozide
